Hensoldt's Record Backlog Meets a Negative Cash Flow: Execution Becomes the Shareholder Test

Hensoldt has no shortage of demand. What it still lacks is the cash to show for it. The defence electronics group closed the first nine months of 2026 with an adjusted free cash flow of minus EUR 104 million — an outflow, to be sure, but a smaller one than the minus EUR 119 million recorded a year earlier. That single line item now frames the whole investment case: a bulging order book is only worth what the company can convert into revenue and, eventually, into available funds.

The scale of that order book is striking. Order intake reached roughly EUR 3.56 billion in the nine-month period, lifting the backlog to a record EUR 10.37 billion. Revenue climbed 21.3% to around EUR 1.86 billion. Adjusted EBITDA advanced 33% to EUR 281 million, and the corresponding margin came in at 15.1%. Operating profit is thus growing faster than sales — a quality signal in itself, provided it eventually feeds through to liquidity.

From Order Intake to Cash Conversion

That gap between earnings and cash is where the debate now sits. Investors who treat the backlog as the foundation of future results must also weigh capacity and project-execution risk. A more favourable reading of Hensoldt becomes credible if the company pairs its operating expansion with a further reduction in cash burn. Management's Operations 2.0 programme is aimed squarely at that bottleneck, designed to clear capacity constraints and smooth supply chains. Its value should be judged on whether more orders actually get worked off, not on the slogan.

Demand-side support is not in question. Higher European defence spending, with air-defence systems and the Eurofighter programmes in particular, continues to underpin the growth story. Additional order momentum could arrive if PEGASUS is awarded before the end of the year; on that assumption, the book-to-bill ratio could approach 2.3. What matters after that is how quickly Hensoldt folds the extra business into its operating plan and delivery schedule.

Should investors sell immediately? Or is it worth buying Hensoldt?

Guidance Sets a Demanding Bar

For the full year 2026, Hensoldt expects revenue of around EUR 2.8 billion and an adjusted EBITDA margin of roughly 19%. Those targets set a stiff benchmark for the remaining quarter. They also sharpen the central risk: a gap between operating growth and financial relief. Such a gap would carry more weight if Hensoldt keeps winning orders while capacity problems persist and the cash outflow continues.

Valuation adds its own pressure. A rich multiple raises the bar for coming reports, and strong demand alone will not justify a more generous rating unless the company makes headway on execution and profitability. Should cash-flow improvement lag the operating expansion, the sceptical camp gains the argument. Tuesday's share-price reaction made the point: despite the solid figures, the stock shed 4.2%.

Two Dates That Could Shift the Narrative

The next concrete catalyst is the capital markets day on 10 November 2026 in London, where commentary on capacity and project delivery could change how investors weigh the story — if it makes the path to better cash generation tangible. Preliminary annual results are then due on 24 February 2027, the next scheduled checkpoint on whether Hensoldt can link its operating momentum to a further cash-flow improvement.

Hensoldt at a turning point? This analysis reveals what investors need to know now.

Until then, the balance is clear enough. As long as operating profitability improves and the cash outflow keeps shrinking, the order base argues for the growth case. If execution stalls and free cash flow deteriorates, valuation risk moves to the fore. For shareholders, the choice comes down to business potential versus delivery quality — and the cash register, not the order book, will settle it.

Ad

Hensoldt Stock: New Analysis - 6 November

Fresh Hensoldt information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Hensoldt analysis...